Diagnostic value of fundus examination in familial adenomatous polyposis
- PMID: 9422927
- PMCID: PMC1722327
- DOI: 10.1136/bjo.81.9.755
Diagnostic value of fundus examination in familial adenomatous polyposis
Abstract
Background: Multiple, bilateral lesions of congenital hypertrophy of the retinal pigment epithelium (CHRPE) have been described in patients suffering from familial adenomatous polyposis (FAP) since 1980. This study aimed to determine a reliable diagnostic criterion, based on the size and number of retinal CHRPE lesions, allowing the screening of patient carriers of the gene responsible for FAP.
Methods: 32 control subjects and 144 patients belonging to 85 FAP families were studied, divided into 124 carriers of the genetic alteration and 20 non-carriers.
Results: In carriers of the deleted gene, multiple, bilateral retinal lesions were consistently observed. Lesion situation, size, shape, and degree of pigmentation were variable however. A positive criterion for FAP was defined as the presence of at least four lesions whatever their size, or at least two lesions one of which is large. This criterion showed a high sensitivity (0.68) and a maximal specificity (1). Within each family, the retinal phenotypic expression was homogeneous. CHRPE lesions were observed in two thirds of the FAP families and absent from the remaining third.
Conclusion: By using this new positive diagnostic criterion, fundus examination allows early detection of those children carrying the gene responsible for FAP in families positive at ocular examination.
Figures
Similar articles
-
Ophthalmic and genetic screening in pedigrees with familial adenomatous polyposis.Am J Ophthalmol. 1998 May;125(5):680-6. doi: 10.1016/s0002-9394(98)00005-1. Am J Ophthalmol. 1998. PMID: 9625552
-
Congenital hypertrophy of retinal pigment epithelium (CHRPE) in patients with familial adenomatous polyposis (FAP); a polyposis registry experience.BMC Res Notes. 2014 Oct 18;7:734. doi: 10.1186/1756-0500-7-734. BMC Res Notes. 2014. PMID: 25326340 Free PMC article.
-
Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis. Novel criteria of assessment and correlations with constitutional adenomatous polyposis coli gene mutations.Cancer. 1996 Dec 1;78(11):2400-10. Cancer. 1996. PMID: 8941012
-
Congenital hypertrophy of the retinal pigment epithelium serves as a clinical marker in a family with familial adenomatous polyposis.J Am Optom Assoc. 1995 Feb;66(2):106-12. J Am Optom Assoc. 1995. PMID: 7714311 Review.
-
Fundus lesions of adenomatous polyposis.Curr Opin Ophthalmol. 1999 Jun;10(3):168-72. doi: 10.1097/00055735-199906000-00003. Curr Opin Ophthalmol. 1999. PMID: 10537774 Review.
Cited by
-
Congenital Hypertrophy of Retinal Pigment Epithelium for Diagnosis of Familial Adenomatous Polyposis - the First FAP registry in Iran.Asian Pac J Cancer Prev. 2018 Jan 27;19(1):167-169. doi: 10.22034/APJCP.2018.19.1.167. Asian Pac J Cancer Prev. 2018. PMID: 29373909 Free PMC article.
-
Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP): Systematic Literature Review and Screening Recommendations.Clin Ophthalmol. 2022 Mar 15;16:765-774. doi: 10.2147/OPTH.S354761. eCollection 2022. Clin Ophthalmol. 2022. PMID: 35321042 Free PMC article. Review.
-
Genetic Counselor Practices Involving Pediatric Patients with FAP: an Investigation of their Self-Reported Strategies for Genetic Testing and Hepatoblastoma Screening.J Genet Couns. 2017 Jun;26(3):586-593. doi: 10.1007/s10897-016-0030-2. Epub 2016 Dec 3. J Genet Couns. 2017. PMID: 27913912
-
Ovoid foveal hyperreflective lesions as a sign of familial adenomatous polyposis: A case series and review.Am J Ophthalmol Case Rep. 2024 Nov 1;36:102217. doi: 10.1016/j.ajoc.2024.102217. eCollection 2024 Dec. Am J Ophthalmol Case Rep. 2024. PMID: 39553912 Free PMC article.
-
Value of the congenital hypertrophy of the retinal pigment epithelium in the diagnosis of familial adenomatous polyposis.Int Ophthalmol. 2004 Mar;25(2):101-12. doi: 10.1023/b:inte.0000031739.62559.ac. Int Ophthalmol. 2004. PMID: 15290889
References
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous